-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Iovance Biotherapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2023 to Q2 2024.
- Iovance Biotherapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$1.46M, a 206% decline year-over-year.
- Iovance Biotherapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$5.87M.
- Iovance Biotherapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was -$3.48M.
- Iovance Biotherapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
- Iovance Biotherapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)